Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mild to Moderate Alzheimer Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00230568
What this trial is testing

EARTH 413: A Study of Aricept in Hispanic Patients With Mild to Moderate Alzheimer's Disease (AD)

Who this might be right for
Alzheimer's Disease
Eisai Inc. 100
Testing effectiveness (Phase 2)Study completedNCT00481520
What this trial is testing

Study Evaluating the Safety,Tolerability, PK and PD of SAM-531 in the Subjects With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Wyeth is now a wholly owned subsidiary of Pfizer 72
Testing effectiveness (Phase 2)Ended earlyNCT00362024
What this trial is testing

MK0952 in Patients With Mild-to-Moderate Alzheimer's Disease (0952-004)(COMPLETED)

Who this might be right for
Alzheimer's Disease
Merck Sharp & Dohme LLC 24
Testing effectiveness (Phase 2)Looking for participantsNCT07058688
What this trial is testing

NTRX-07 in Participants With Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseMild Cognitive Impairment
NeuroTherapia, Inc. 48
Testing effectiveness (Phase 2)Study completedNCT00940589
What this trial is testing

Efficacy of Circadin® 2 mg in Patients With Mild to Moderate Alzheimer Disease Treated With AChE Inhibitor

Who this might be right for
Alzheimer's DiseaseSleep Disorder
Neurim Pharmaceuticals Ltd. 73
Testing effectiveness (Phase 2)UnknownNCT04388982
What this trial is testing

The Safety and the Efficacy Evaluation of Allogenic Adipose MSC-Exos in Patients With Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Ruijin Hospital 9
Large-scale testing (Phase 3)Ended earlyNCT05575076
What this trial is testing

Open-label Extension for Phase 3 Clinical Trials of Simufilam

Who this might be right for
Alzheimer Disease
Cassava Sciences, Inc. 1,081
Testing effectiveness (Phase 2)Ended earlyNCT05352763
What this trial is testing

Open-Label Extension of the PTI-125-04 Study in Mild-to-Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Cassava Sciences, Inc. 90
Not applicableStudy completedNCT05454540
What this trial is testing

Repetitive TMS of the Posterior DMN in AD

Who this might be right for
Alzheimer Disease
I.R.C.C.S. Fondazione Santa Lucia 60
Large-scale testing (Phase 3)Looking for participantsNCT06976216
What this trial is testing

Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Bristol-Myers Squibb 586
Early research (Phase 1)Study completedNCT03522129
What this trial is testing

Study to Evaluate the Effect of CT1812 Treatment on Amyloid Beta Oligomer Displacement Into CSF in Subjects With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Cognition Therapeutics 3
Post-approval studies (Phase 4)Study completedNCT01529619
What this trial is testing

Efficacy, Safety and Tolerability of Rivastigmine Patch in Patients With Mild to Moderate Alzheimer's Disease Switched From Cholinesterase Inhibitors

Who this might be right for
Alzheimer's Disease
Novartis Pharmaceuticals 52
Early research (Phase 1)Study completedNCT00757939
What this trial is testing

Assess Regional Cerebral Blood Flow as an Alzheimer's Disease Biomarker Compared to Positron Emission Tomography in Patients With Mild-to-Moderate Alzheimer's Disease and Cognitively Normal Elderly Subjects (Study MK-0000-068)(COMPLETED)

Who this might be right for
Alzheimer's Disease
Merck Sharp & Dohme LLC 40
Large-scale testing (Phase 3)Study completedNCT00575055
What this trial is testing

Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Carrier)

Who this might be right for
Alzheimer's Disease
JANSSEN Alzheimer Immunotherapy Research & Development, LLC 1,121
Not applicableStudy completedNCT02187276
What this trial is testing

The Predictive Factors of Good Clinical Response to Cholinesterase Inhibitors in Alzheimer Disease and Mixed Dementia

Who this might be right for
Alzheimer Disease, Late Onset
Federal University of Minas Gerais 129
Testing effectiveness (Phase 2)Study completedNCT00142805
What this trial is testing

Tricaprilin in Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Cerecin 152
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07789873
What this trial is testing

A 28-Day Study of GAL-101 in Participants With Mild to Moderate Alzheimer's Disease

Who this might be right for
Mild to Moderate Alzheimer's Disease
Galimedix Therapeutics Inc 100
Not applicableNot Yet RecruitingNCT07773493
What this trial is testing

A Mobile Informatics Solution to Assist Caregivers in Care Coordination and Monitoring Social Engagement

Who this might be right for
Memory DisordersMild Cognitive ImpairmentDementia+2 more
University of Minnesota 200
Early research (Phase 1)Study completedNCT00117403
What this trial is testing

Anti-Oxidant Treatment of Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
National Institute on Aging (NIA) 75
Not applicableStudy completedNCT05433493
What this trial is testing

Effect of Individual Cognitive Stimulation on Memory and Executive Function in Older Adults With Alzheimer's Disease

Who this might be right for
DementiaNeurocognitive DisordersCognitive Impairment+2 more
Rsocialform - Geriatria, Lda 142
Next Page